Literature DB >> 19451650

Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication.

Satoko Iwahori1, Takayuki Murata, Ayumi Kudoh, Yoshitaka Sato, Sanae Nakayama, Hiroki Isomura, Teru Kanda, Tatsuya Tsurumi.   

Abstract

Epstein-Barr virus (EBV) productive replication occurs in an S-phase-like cellular environment with high cyclin-dependent kinase (CDK) activity. The EBV protein kinase (PK), encoded by the viral BGLF4 gene, is a Ser/Thr protein kinase, which phosphorylates both viral and cellular proteins, modifying the cellular environment for efficient viral productive replication. We here provide evidence that the EBV PK phosphorylates the CDK inhibitor p27(Kip1), resulting in ubiquitination and degradation in a proteasome-dependent manner during EBV productive replication. Experiments with BGLF4 knockdown by small interfering RNA and BGLF4 knock-out viruses clarified that EBV PK is involved in p27(Kip1) degradation upon lytic replication. Transfection of the BGLF4 expression vector revealed that EBV PK alone could phosphorylate the Thr-187 residue of p27(Kip1) and that the ubiquitination and degradation of p27(Kip1) occurred in an SCF(Skp2) ubiquitin ligase-dependent manner. In vitro, EBV PK proved capable of phosphorylating p27(Kip1) at Thr-187. Unlike cyclin E-CDK2 activity, the EBV PK activity was not inhibited by p27(Kip1). Overall, EBV PK enhances p27(Kip1) degradation effectively upon EBV productive replication, contributing to establishment of an S-phase-like cellular environment with high CDK activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451650      PMCID: PMC2707218          DOI: 10.1074/jbc.M109.015123

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.

Authors:  L M Tsvetkov; K H Yeh; S J Lee; H Sun; H Zhang
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

2.  Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.

Authors:  Ayumi Kudoh; Tohru Daikoku; Yutaka Sugaya; Hiroki Isomura; Masatoshi Fujita; Tohru Kiyono; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 3.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

4.  Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.

Authors:  F Le Roux; A Sergeant; L Corbo
Journal:  J Gen Virol       Date:  1996-03       Impact factor: 3.891

5.  Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.

Authors:  N Shimizu; A Tanabe-Tochikura; Y Kuroiwa; K Takada
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.

Authors:  C Swanton; D J Mann; B Fleckenstein; F Neipel; G Peters; N Jones
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

7.  The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase.

Authors:  Xiaobing Deng; Stephen E Mercer; Sejal Shah; Daina Z Ewton; Eileen Friedman
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

8.  Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.

Authors:  M Ellis; Y P Chew; L Fallis; S Freddersdorf; C Boshoff; R A Weiss; X Lu; S Mittnacht
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

9.  Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.

Authors:  D J Mann; E S Child; C Swanton; H Laman; N Jones
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

10.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  16 in total

1.  Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication.

Authors:  Renfeng Li; Jian Zhu; Zhi Xie; Gangling Liao; Jianyong Liu; Mei-Ru Chen; Shaohui Hu; Crystal Woodard; Jimmy Lin; Sean D Taverna; Prashant Desai; Richard F Ambinder; Gary S Hayward; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

2.  Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

Authors:  Shinichi Saito; Takayuki Murata; Teru Kanda; Hiroki Isomura; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

3.  SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.

Authors:  Renfeng Li; Leyao Wang; Gangling Liao; Catherine M Guzzo; Michael J Matunis; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

4.  Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant.

Authors:  Qiao Meng; Stacy R Hagemeier; Chad V Kuny; Robert F Kalejta; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

5.  Key motifs in EBV (Epstein-Barr virus)-encoded protein kinase for phosphorylation activity and nuclear localization.

Authors:  Svetlana Gershburg; Leann Murphy; Manfred Marschall; Edward Gershburg
Journal:  Biochem J       Date:  2010-10-15       Impact factor: 3.857

6.  The Ying-Yang of the virus-host interaction: control of the DNA damage response.

Authors:  Renfeng Li; S Diane Hayward
Journal:  Future Microbiol       Date:  2011-04       Impact factor: 3.165

7.  Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk).

Authors:  Angie C Umaña; Satoko Iwahori; Robert F Kalejta
Journal:  ACS Chem Biol       Date:  2017-12-19       Impact factor: 5.100

8.  Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinases.

Authors:  Chad V Kuny; Karen Chinchilla; Michael R Culbertson; Robert F Kalejta
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

9.  Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells.

Authors:  Xiaoping Sun; Jillian A Bristol; Satoko Iwahori; Stacy R Hagemeier; Qiao Meng; Elizabeth A Barlow; Joyce D Fingeroth; Vera L Tarakanova; Robert F Kalejta; Shannon C Kenney
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

Review 10.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.